MiMedx Group, Inc. Accrued Professional Fees
MiMedx Group, Inc. (MDXG) had Accrued Professional Fees of $3.20 million as of 2022-06-30, per its 10-Q filed 2022-08-02.
Discontinued › Notes
us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent · last filed 2022-08-02
- 2022-06-30: Accrued Professional Fees $3.20M.
- 2022-03-31: Accrued Professional Fees $3.21M.
- 2021-12-31: Accrued Professional Fees $2.81M.
- 2021-09-30: Accrued Professional Fees $8.10M.
| Period end | Accrued Professional Fees | Accrued Professional Fees as first filed |
|---|---|---|
| 2022-06-30 | $3.20M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $3.21M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $2.81M 10-Q · filed 2022-08-02 | |
| 2021-09-30 | $8.10M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $7.16M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $18.81M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $24.80M 10-K · filed 2022-02-28 | $14.82M 10-K · filed 2021-03-08 |
| 2020-09-30 | $15.09M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $15.07M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $13.30M 10-Q · filed 2020-07-06 | |
| 2019-12-31 | $12.20M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $16.58M 10-Q · filed 2020-07-06 | |
| 2019-06-30 | $19.37M 10-Q · filed 2020-07-06 | |
| 2019-03-31 | $14.25M 10-Q · filed 2020-07-06 | |
| 2018-12-31 | $10.06M 10-K · filed 2020-07-06 | |
| 2017-12-31 | $3.76M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |